Brooklyn Investment Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Brooklyn Investment Group’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,061	Closed	-$75.5K	–	1565
2025 Q3	$75.5K	Buy	16,061 +11,110	+224%	+$74.4K	0.01%	648
2025 Q2	$22.3K	Sell	4,951 -972	-16%	-$4.37K	﹤0.01%	1773
2025 Q1	$26.2K	Buy	5,923 +5,796	+4,564%	+$33.6K	0.01%	1040
2024 Q4	$995	Buy	+127	New	+$1.55K	﹤0.01%	1599

Brooklyn Investment Group's YMAB Position: Q4 2025 in Review

Brooklyn Investment Group sold out of Y-mAbs Therapeutics (YMAB) in Q4 2025, closing a stake of 16,061 shares — an estimated $75.5K sold.

Brooklyn Investment Group first reported a position in YMAB in Q4 2024 and held it in 4 quarters. The position peaked at $75.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold YMAB as of Q4 2025.

Brooklyn Investment Group reported no remaining Y-mAbs Therapeutics position as of Q4 2025 after selling out during the quarter.
Brooklyn Investment Group sold 16,061 Y-mAbs Therapeutics shares in Q4 2025, an estimated $75.5K.
Brooklyn Investment Group first reported a position in Y-mAbs Therapeutics in Q4 2024 and held it in 4 quarters.
Brooklyn Investment Group's Y-mAbs Therapeutics position peaked at $75.5K in Q3 2025.
0 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.